CCL Products (India) Limited announced the exercise of 319 equity shares under its Employee Stock Option Scheme 2022 on March 18, 2026. The shares were exercised at Rs. 2/- per share with no premium, matching the face value. The company confirmed no change in paid-up share capital and that the new shares rank pari-passu with existing shares.

CCL Products Exercises 319 Employee Stock Options Under 2022 Scheme

CCL Products (India) Limited has announced the exercise of 319 equity shares under its Employee Stock Option Scheme 2022, marking another milestone in the company's employee benefit initiatives. The exercise was completed by an eligible employee on March 18, 2026, following the completion of the applicable vesting period.

ESOP Exercise Details

The company has provided comprehensive details regarding the stock option exercise in compliance with SEBI regulations. The shares were transferred from the CCL Employees Trust, which was established specifically for implementing the employee stock option scheme.

Parameter Details Number of Shares Exercised 319 Exercise Date March 18, 2026 Exercise Price per Share Rs. 2/- Face Value per Share Rs. 2/- Premium per Share Nil Distinctive Numbers 133198038 to 133198356

Share Capital Impact

The company has clarified that this exercise does not result in any change to its paid-up share capital. The allotted shares will rank pari-passu with the existing shares of the company, ensuring equal rights and privileges for all shareholders.

Share Capital Details Amount/Number Total Issued Shares After Exercise 13,35,27,920 Total Issued Share Capital Rs. 26,70,55,840/- Share Denomination Rs. 2/- each

Regulatory Compliance

The disclosure has been made pursuant to Regulation 10 of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The company has filed the necessary documentation with both NSE and BSE, maintaining transparency with the stock exchanges.

Key compliance aspects include:

Shares issued in demat form with no physical certificates

No lock-in period applicable to the exercised shares

Shares identical in all respects to existing equity shares

No additional listing fees payable

Scheme Background

The CCL Employee Stock Option Scheme 2022 was previously filed with the stock exchanges in two tranches. The initial filing for 4,00,000 shares was completed in September 2022, followed by an additional filing for 1,00,000 shares in February 2024. This systematic approach demonstrates the company's commitment to structured employee benefit programs and regulatory compliance.

CCL Products (I) Ltd. has recorded a significant block trade transaction on the National Stock Exchange (NSE), highlighting substantial institutional investor activity in the coffee processing company's shares.

Block Trade Details

The transaction represents a noteworthy development in the company's trading activity, with specific parameters indicating the scale and pricing of the deal.

Parameter: Details Total Transaction Value: ₹21.93 crores Number of Shares: 209,734 shares Price Per Share: ₹1,045.60 Exchange: NSE

Market Significance

Block trades are typically executed by institutional investors, mutual funds, or other large market participants seeking to transact substantial volumes without impacting regular market prices. These transactions occur outside normal trading hours and provide an efficient mechanism for large-scale equity transfers.

The pricing of ₹1,045.60 per share reflects the negotiated rate between the participating parties in this block deal. Such transactions often indicate strategic portfolio rebalancing, stake acquisitions, or divestments by institutional investors.

Transaction Impact

The ₹21.93 crore transaction value demonstrates significant investor interest in CCL Products' equity. Block trades of this magnitude typically involve careful consideration of market conditions and company fundamentals by the participating institutional entities.

This block trade activity adds to the overall trading volume and liquidity in CCL Products' shares, providing market participants with additional data points regarding institutional investor sentiment toward the company's prospects.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.